Suvretta Capital Management
Latest statistics and disclosures from Suvretta Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPY, ARQT, BNTC, META, LEGN, and represent 28.64% of Suvretta Capital Management's stock portfolio.
- Added to shares of these 10 stocks: SPY (+$67M), KDP (+$66M), XBI (+$50M), MSOS (+$34M), RNA (+$33M), PROK (+$30M), CRM (+$30M), HD (+$27M), FERG (+$26M), CMPX (+$24M).
- Started 10 new stock positions in XBI, NOW, MRVL, SNOW, KDP, MSOS, CRM, RNA, UTHR, PROK.
- Reduced shares in these 10 stocks: IWM (-$152M), NVDA (-$96M), ETNB (-$87M), GEHC (-$39M), DKS (-$29M), DDOG (-$24M), ARQT (-$20M), MRNA (-$14M), KYMR (-$12M), EYPT (-$8.7M).
- Sold out of its positions in ALGN, BAX, CZR, DDOG, GEHC, IWM, KYMR, MRNA, OS, PEPG. TSHA, UAL, WING, CRH, Prokidney Corp Class A Ord.
- Suvretta Capital Management was a net buyer of stock by $35M.
- Suvretta Capital Management has $3.9B in assets under management (AUM), dropping by 17.77%.
- Central Index Key (CIK): 0001569064
Tip: Access up to 7 years of quarterly data
Positions held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Suvretta Capital Management
Suvretta Capital Management holds 92 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 13.6 | $533M | +14% | 800k | 666.18 |
|
| Arcutis Biotherapeutics (ARQT) | 5.1 | $198M | -9% | 11M | 18.85 |
|
| Benitec Biopharma Com New (BNTC) | 3.5 | $139M | 9.9M | 14.03 |
|
|
| Meta Platforms Cl A (META) | 3.2 | $126M | 171k | 734.38 |
|
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 3.2 | $125M | 3.8M | 32.61 |
|
|
| 89bio (ETNB) | 3.1 | $122M | -41% | 8.3M | 14.70 |
|
| Immatics SHS (IMTX) | 2.6 | $103M | 12M | 8.52 |
|
|
| Coca-Cola Company (KO) | 2.5 | $97M | +17% | 1.5M | 66.32 |
|
| Ge Aerospace Com New (GE) | 2.4 | $93M | 310k | 300.82 |
|
|
| NVIDIA Corporation (NVDA) | 2.3 | $90M | -51% | 484k | 186.58 |
|
| Eyepoint Pharmaceuticals Com New (EYPT) | 2.3 | $88M | -8% | 6.2M | 14.24 |
|
| Biohaven (BHVN) | 2.2 | $84M | 5.6M | 15.01 |
|
|
| Mineralys Therapeutics (MLYS) | 2.1 | $81M | +22% | 2.1M | 37.92 |
|
| Home Depot (HD) | 2.0 | $80M | +50% | 197k | 405.19 |
|
| Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 2.0 | $77M | -7% | 277k | 279.29 |
|
| Kura Oncology (KURA) | 1.8 | $72M | 8.1M | 8.85 |
|
|
| Ferguson Enterprises Common Stock New (FERG) | 1.8 | $69M | +61% | 306k | 224.58 |
|
| Arrivent Biopharma (AVBP) | 1.7 | $68M | +8% | 3.7M | 18.45 |
|
| Keurig Dr Pepper (KDP) | 1.7 | $66M | NEW | 2.6M | 25.51 |
|
| Apellis Pharmaceuticals (APLS) | 1.7 | $65M | 2.9M | 22.63 |
|
|
| Advanced Micro Devices (AMD) | 1.7 | $65M | 399k | 161.79 |
|
|
| Oracle Corporation (ORCL) | 1.6 | $64M | 226k | 281.24 |
|
|
| Ultragenyx Pharmaceutical (RARE) | 1.6 | $61M | -11% | 2.0M | 30.08 |
|
| Bank of America Corporation (BAC) | 1.5 | $60M | +25% | 1.2M | 51.59 |
|
| Kalvista Pharmaceuticals (KALV) | 1.5 | $58M | -3% | 4.8M | 12.18 |
|
| Apollo Global Mgmt (APO) | 1.5 | $58M | 431k | 133.27 |
|
|
| Microsoft Corporation (MSFT) | 1.5 | $57M | +10% | 110k | 517.95 |
|
| Palvella Therapeutics Inc Ne (PVLA) | 1.3 | $52M | +15% | 822k | 62.69 |
|
| Capital One Financial (COF) | 1.3 | $51M | +22% | 239k | 212.58 |
|
| Danaher Corporation (DHR) | 1.3 | $51M | +46% | 256k | 198.26 |
|
| Arcus Biosciences Incorporated (RCUS) | 1.3 | $50M | 3.7M | 13.60 |
|
|
| Spdr Series Trust S&p Biotech Put Option (XBI) | 1.3 | $50M | NEW | 500k | 100.20 |
|
| Fulcrum Therapeutics (FULC) | 1.3 | $50M | +5% | 5.4M | 9.20 |
|
| Compass Therapeutics (CMPX) | 1.3 | $49M | +97% | 14M | 3.50 |
|
| Amazon (AMZN) | 1.2 | $48M | -15% | 219k | 219.57 |
|
| Tesla Motors (TSLA) | 1.0 | $41M | 91k | 444.72 |
|
|
| Boston Scientific Corporation (BSX) | 0.9 | $35M | 354k | 97.63 |
|
|
| Advisorshares Tr Pure Us Cannabis (MSOS) | 0.9 | $34M | NEW | 7.2M | 4.79 |
|
| UnitedHealth (UNH) | 0.9 | $33M | +41% | 96k | 345.30 |
|
| Avidity Biosciences Ord (RNA) | 0.8 | $33M | NEW | 750k | 43.57 |
|
| Erasca (ERAS) | 0.8 | $32M | 15M | 2.18 |
|
|
| Insmed Com Par $.01 (INSM) | 0.8 | $31M | -8% | 218k | 144.01 |
|
| Prokidney Corp Shs Cl A (PROK) | 0.8 | $30M | NEW | 12M | 2.42 |
|
| salesforce (CRM) | 0.8 | $30M | NEW | 125k | 237.00 |
|
| Dick's Sporting Goods (DKS) | 0.7 | $29M | -50% | 128k | 222.22 |
|
| Aura Biosciences (AURA) | 0.7 | $27M | 4.4M | 6.18 |
|
|
| Monte Rosa Therapeutics (GLUE) | 0.6 | $25M | 3.4M | 7.41 |
|
|
| Johnson & Johnson (JNJ) | 0.6 | $25M | 133k | 185.42 |
|
|
| Zura Bio Class A Ord Shs (ZURA) | 0.6 | $24M | +12% | 5.5M | 4.33 |
|
| Biogen Idec (BIIB) | 0.6 | $24M | +10% | 168k | 140.08 |
|
| Marvell Technology (MRVL) | 0.6 | $23M | NEW | 272k | 84.07 |
|
| Servicenow (NOW) | 0.5 | $20M | NEW | 22k | 920.28 |
|
| Contineum Therapeutics Cl A (CTNM) | 0.5 | $20M | 1.7M | 11.75 |
|
|
| Snowflake Com Shs (SNOW) | 0.5 | $20M | NEW | 89k | 225.55 |
|
| Goldman Sachs (GS) | 0.5 | $19M | 24k | 796.35 |
|
|
| Merck & Co (MRK) | 0.5 | $18M | 219k | 83.93 |
|
|
| Pinterest Cl A (PINS) | 0.4 | $16M | +15% | 497k | 32.17 |
|
| Abeona Therapeutics Com New (ABEO) | 0.4 | $14M | 2.7M | 5.28 |
|
|
| Rocket Pharmaceuticals (RCKT) | 0.3 | $13M | -7% | 3.8M | 3.26 |
|
| Regeneron Pharmaceuticals (REGN) | 0.3 | $10M | +105% | 18k | 562.27 |
|
| Inflarx Nv (IFRX) | 0.2 | $8.7M | 6.5M | 1.34 |
|
|
| Molecular Partners Ads (MOLN) | 0.2 | $8.2M | 2.2M | 3.71 |
|
|
| Aadi Bioscience (WHWK) | 0.2 | $7.0M | 3.7M | 1.90 |
|
|
| Abbott Laboratories (ABT) | 0.2 | $6.8M | +25% | 51k | 133.94 |
|
| Thermo Fisher Scientific (TMO) | 0.2 | $6.5M | +69% | 13k | 485.02 |
|
| Sutro Biopharma (STRO) | 0.1 | $5.6M | 6.5M | 0.87 |
|
|
| EXACT Sciences Corporation (EXAS) | 0.1 | $5.1M | 94k | 54.71 |
|
|
| Elanco Animal Health (ELAN) | 0.1 | $5.1M | 254k | 20.14 |
|
|
| AmerisourceBergen (COR) | 0.1 | $3.9M | 13k | 312.53 |
|
|
| United Therapeutics Corporation (UTHR) | 0.1 | $3.1M | NEW | 7.5k | 419.21 |
|
| Kezar Life Sciences Com New (KZR) | 0.1 | $2.8M | 717k | 3.90 |
|
|
| Mettler-Toledo International (MTD) | 0.1 | $2.4M | 2.0k | 1227.61 |
|
|
| Medtronic SHS (MDT) | 0.1 | $2.4M | 25k | 95.24 |
|
|
| Intuitive Surgical Com New (ISRG) | 0.1 | $2.3M | 5.2k | 447.23 |
|
|
| Stryker Corporation (SYK) | 0.1 | $2.2M | 5.9k | 369.67 |
|
|
| Dex (DXCM) | 0.1 | $2.1M | 32k | 67.29 |
|
|
| Natera (NTRA) | 0.0 | $1.6M | 10k | 160.97 |
|
|
| McKesson Corporation (MCK) | 0.0 | $1.4M | 1.8k | 772.54 |
|
|
| Iqvia Holdings (IQV) | 0.0 | $1.4M | 7.2k | 189.94 |
|
|
| Hca Holdings (HCA) | 0.0 | $1.4M | 3.2k | 426.20 |
|
|
| Galapagos Nv Spon Adr (GLPG) | 0.0 | $1.3M | 37k | 34.64 |
|
|
| Waters Corporation (WAT) | 0.0 | $944k | 3.2k | 299.81 |
|
|
| Avantor (AVTR) | 0.0 | $897k | 72k | 12.48 |
|
|
| Edwards Lifesciences (EW) | 0.0 | $863k | 11k | 77.77 |
|
|
| Ionis Pharmaceuticals (IONS) | 0.0 | $707k | 11k | 65.42 |
|
|
| ResMed (RMD) | 0.0 | $654k | 2.4k | 273.73 |
|
|
| Agilent Technologies Inc C ommon (A) | 0.0 | $641k | 5.0k | 128.35 |
|
|
| Veralto Corp Com Shs (VLTO) | 0.0 | $584k | 5.5k | 106.61 |
|
|
| Steris Shs Usd (STE) | 0.0 | $379k | 1.5k | 247.44 |
|
|
| Sarepta Therapeutics (SRPT) | 0.0 | $345k | 18k | 19.27 |
|
|
| Zimmer Holdings (ZBH) | 0.0 | $321k | 3.3k | 98.50 |
|
|
| Pacs Group Com Shs (PACS) | 0.0 | $275k | 20k | 13.73 |
|
Past Filings by Suvretta Capital Management
SEC 13F filings are viewable for Suvretta Capital Management going back to 2013
- Suvretta Capital Management 2025 Q3 filed Nov. 14, 2025
- Suvretta Capital Management 2025 Q2 filed Aug. 14, 2025
- Suvretta Capital Management 2025 Q1 filed May 15, 2025
- Suvretta Capital Management 2024 Q4 filed Feb. 14, 2025
- Suvretta Capital Management 2024 Q3 filed Nov. 14, 2024
- Suvretta Capital Management 2024 Q2 filed Aug. 14, 2024
- Suvretta Capital Management 2024 Q1 filed May 15, 2024
- Suvretta Capital Management 2023 Q3 filed Nov. 14, 2023
- Suvretta Capital Management 2023 Q2 filed Aug. 14, 2023
- Suvretta Capital Management 2023 Q1 filed May 15, 2023
- Suvretta Capital Management 2022 Q4 filed Feb. 14, 2023
- Suvretta Capital Management 2022 Q3 filed Nov. 14, 2022
- Suvretta Capital Management 2022 Q2 filed Aug. 15, 2022
- Suvretta Capital Management 2022 Q1 filed May 16, 2022
- Suvretta Capital Management 2021 Q4 filed Feb. 14, 2022
- Suvretta Capital Management 2021 Q3 restated filed Nov. 16, 2021